These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26477395)

  • 1. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
    de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR
    Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy.
    de Bree R; van der Putten L; Hoekstra OS; Kuik DJ; Uyl-de Groot CA; van Tinteren H; Leemans CR; Boers M;
    Contemp Clin Trials; 2007 Nov; 28(6):705-12. PubMed ID: 17459783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
    Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
    van Hooren AC; Brouwer J; de Bree R; Hoekstra OS; Leemans CR; Uyl-de Groot CA
    Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1441-8. PubMed ID: 19043728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
    Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
    J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
    Wedman J; Pruim J; van der Putten L; Hoekstra OS; de Bree R; van Dijk BAC; van der Laan BFAM
    Clin Otolaryngol; 2019 Mar; 44(2):124-130. PubMed ID: 30315624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
    Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M
    HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
    Terhaard CH; Bongers V; van Rijk PP; Hordijk GJ
    Head Neck; 2001 Nov; 23(11):933-41. PubMed ID: 11754496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of
    Kim SY; Crook D; Rosskopf J; Lee JH
    Head Neck; 2024 Sep; 46(9):2284-2291. PubMed ID: 38712471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.
    Brouwer J; Bodar EJ; De Bree R; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Eur Arch Otorhinolaryngol; 2004 Sep; 261(8):417-22. PubMed ID: 14625779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
    Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
    Liu FY; Lin CY; Chang JT; Ng SH; Chin SC; Wang HM; Liao CT; Chan SC; Yen TC
    J Nucl Med; 2007 Oct; 48(10):1614-9. PubMed ID: 17873135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
    Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
    Kim HJ; Boyd J; Dunphy F; Lowe V
    Clin Nucl Med; 1998 Nov; 23(11):750-2. PubMed ID: 9814562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
    van der Putten L; Hoekstra OS; de Bree R; Kuik DJ; Comans EF; Langendijk JA; Leemans CR
    Mol Imaging Biol; 2008 Sep; 10(5):294-303. PubMed ID: 18622649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
    Bongers V; Hobbelink MG; van Rijk PP; Hordijk GJ
    Cancer Biother Radiopharm; 2002 Jun; 17(3):303-6. PubMed ID: 12136522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma-a review.
    Seebauer CT; Hackenberg B; Grosse J; Rennert J; Jung EM; Ugele I; Michaelides I; Mehanna H; Hautmann MG; Bohr C; Künzel J
    Strahlenther Onkol; 2021 Mar; 197(3):167-176. PubMed ID: 33216194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma].
    Alvarez Pérez RM; Borrego Dorado I; Vázquez Albertino R; Ruiz Franco-Baux J; Ceballo Pedraja JM; Esteban Ortega F
    Acta Otorrinolaringol Esp; 2006 Mar; 57(3):134-9. PubMed ID: 16615566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
    Roh JL; Pae KH; Choi SH; Kim JS; Lee S; Kim SB; Nam SY; Kim SY
    Eur J Surg Oncol; 2007 Aug; 33(6):790-5. PubMed ID: 17306956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.